The stock is up by 30 per cent in 1 year and over 100 per cent in 3 years.

At the pre-opening bell, the frontline index S&P BSE Sensex opened in green with a gain of 111.75 points or 0.17 per cent.

Shares of this company jumped more than 70 per cent in the last six months.

Shares of the company have gained about 100 per cent in the last six months.

The company's financial performance for the quarter ended November 7, 2023, was strong, with both revenue and profit increasing from the previous quarter. Total revenue from operations increased by 11.85 per cent to Rs. 39.80 crores, while net profit increased by 10.26 per cent to Rs. 5.65 crores. The company's stock price also reflected its strong performance, reaching a new 52-week high of Rs. 344.00 on November 7, 2023, on high volume.

Neuland Laboratories, in an impressive Q2FY24 performance, has seen a remarkable 43 per cent year-on-year growth in its Contract Manufacturing Services (CMS) vertical, propelling the company's EBITDA margin to a substantial 33.4 per cent, a remarkable 980 basis points increase YoY. This remarkable progress can be attributed to both higher revenues and a strategic shift towards high-margin business

The stock is up by 57 per cent in 1 year and gave multibagger returns of over 200 per cent in the last 3 years.

Over the past six months shares of the company have given an amazing return of 71.37 per cent.

The shares of the company have a PE of 11.5x whereas the industry PE is 24x and an ROE of 28 per cent.

To fuel its growth strategy, the company is raising Rs 125 crore through a preferential allotment.